These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 33691652)

  • 1. Exosomes for mRNA delivery: a novel biotherapeutic strategy with hurdles and hope.
    Aslan C; Kiaie SH; Zolbanin NM; Lotfinejad P; Ramezani R; Kashanchi F; Jafari R
    BMC Biotechnol; 2021 Mar; 21(1):20. PubMed ID: 33691652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosome for mRNA delivery: strategies and therapeutic applications.
    Iqbal Z; Rehman K; Mahmood A; Shabbir M; Liang Y; Duan L; Zeng H
    J Nanobiotechnology; 2024 Jul; 22(1):395. PubMed ID: 38965553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosome-Mediated Targeted Delivery of miRNAs.
    Ohno S; Kuroda M
    Methods Mol Biol; 2016; 1448():261-70. PubMed ID: 27317187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and microRNA profiling of exosomes derived from blood and culture media.
    McDonald MK; Capasso KE; Ajit SK
    J Vis Exp; 2013 Jun; (76):e50294. PubMed ID: 23792786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinspired cellular membrane-derived vesicles for mRNA delivery.
    Xu X; Xu L; Wang J; Wen C; Xia J; Zhang Y; Liang Y
    Theranostics; 2024; 14(8):3246-3266. PubMed ID: 38855184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering exosomes for targeted drug delivery.
    Liang Y; Duan L; Lu J; Xia J
    Theranostics; 2021; 11(7):3183-3195. PubMed ID: 33537081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome-mediated mRNA delivery in vivo is safe and can be used to induce SARS-CoV-2 immunity.
    Tsai SJ; Atai NA; Cacciottolo M; Nice J; Salehi A; Guo C; Sedgwick A; Kanagavelu S; Gould SJ
    J Biol Chem; 2021 Nov; 297(5):101266. PubMed ID: 34600888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic modified messenger RNA for therapeutic applications.
    Gao M; Zhang Q; Feng XH; Liu J
    Acta Biomater; 2021 Sep; 131():1-15. PubMed ID: 34133982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes as drug delivery systems: A brief overview and progress update.
    Patil SM; Sawant SS; Kunda NK
    Eur J Pharm Biopharm; 2020 Sep; 154():259-269. PubMed ID: 32717385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in exosome-mediated nucleic acid delivery for cancer therapy.
    Zhang Y; Liu Q; Zhang X; Huang H; Tang S; Chai Y; Xu Z; Li M; Chen X; Liu J; Yang C
    J Nanobiotechnology; 2022 Jun; 20(1):279. PubMed ID: 35701788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex Coacervates as a Promising Vehicle for mRNA Delivery: A Comprehensive Review of Recent Advances and Challenges.
    Forenzo C; Larsen J
    Mol Pharm; 2023 Sep; 20(9):4387-4403. PubMed ID: 37561647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
    Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for Targeting Peptide-Modified Exosomes and Their Applications in the Lungs.
    Qiu M; Zou J; Yang Z; Yang D; Wang R; Guo H
    Int J Nanomedicine; 2024; 19():8175-8188. PubMed ID: 39157733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes: Nanoparticulate tools for RNA interference and drug delivery.
    Shahabipour F; Barati N; Johnston TP; Derosa G; Maffioli P; Sahebkar A
    J Cell Physiol; 2017 Jul; 232(7):1660-1668. PubMed ID: 28063231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy.
    Wang X; Zhang H; Yang H; Bai M; Ning T; Li S; Li J; Deng T; Ying G; Ba Y
    Curr Cancer Drug Targets; 2018; 18(4):347-354. PubMed ID: 28699500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Biological Function and Therapeutic Potential of Exosomes in Cancer: Exosomes as Efficient Nanocommunicators for Cancer Therapy.
    Choi JU; Park IK; Lee YK; Hwang SR
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33028046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microfluidic fabrication of cell-derived nanovesicles as endogenous RNA carriers.
    Jo W; Jeong D; Kim J; Cho S; Jang SC; Han C; Kang JY; Gho YS; Park J
    Lab Chip; 2014 Apr; 14(7):1261-9. PubMed ID: 24493004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering Exosomes for Cancer Therapy.
    Gilligan KE; Dwyer RM
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28538671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
    Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
    J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of synthetic mRNAs for tissue regeneration.
    Steinle H; Weber J; Stoppelkamp S; Große-Berkenbusch K; Golombek S; Weber M; Canak-Ipek T; Trenz SM; Schlensak C; Avci-Adali M
    Adv Drug Deliv Rev; 2021 Dec; 179():114007. PubMed ID: 34710530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.